Нарушения обмена глюкозы у новорожденных детей

113. Iglesias Platas Thio Lluch М., Pociello Alminana N., Morillo Palomo A., Iriondo SanzM., Krauel Vidal X. Continuous glucose monitoring in infants of very low birth weight. Neonatology. 2009. Vol. 95. P. 217–223.

114. Inder T. How low can I go? The impact of hypoglycemia on the immature brain. Pediatrics. 2008;Vol. 122, N 2. P. 440–441.

115. JonssonJ., Carlsson L., Edlund Т., EdlundH. Insulin-promoter-factor 1 is required for pancreas development in mice // Nature, 1994 Oct 13. Vol. 371, N 6498. P. 606–609.

116. Julier C., Nicolino M. Wolcott-Rallison syndrome // Orphanet. J. Rare Dis. 2010. Vol. 4. P. 5–29.

117. Kalhan S. C., Oliven A., King К. C., Lucero C. Role of glucose in the regulation of endogenous glucose production in the human newborn // Pediatric research. 1986. Vol. 20. P. 49–52.

118. Kalhan S. C., Parimi P. S. Metabolic and endocrine disorders, part one: disorders of carbohydrate metabolism // Neonatal-Perinatal Medicine: Diseases of the Fetus and Newborn.

8. / Martin R. J., Fanaroff A. A., Walsh М. C., editors. Philadelphia: Mosby-Elsevier, 2006. P. 1467–1491.

119. Kalhan S. C., Parimi P., Van Beek R., Gilfillan C., Saker F., Gruca L., Sauer P. J. Estimation of gluconeogenesis in newborn infants // Am. J. Physiol. Endocrinol. Metab. 2001. Vol. 281, N 5. P. 991–997.

120. Kalhan S. C., Savin S. М., Adam P. A. J. Measurement of glucose turnover in the human newborn with glucose-l-13C // Journal of clinical endocrinology and metabolism. 1976. Vol. 43. P. 704–707.

121. KatzL. E., Ferry R. J., Stanley C. A., Collett-SolbergP. F., Baker L., Cohen P. Suppression of insulin oversecretion by subcutaneous recombinant human insulin-like growth factor I in children with congenital hyperinsulinism due to defective beta-cell sulfonylurea receptor//J. Clin. Endocrinol. Metab. 1999. Vol. 84. P. 3117–3124.

122. Kayiran S. М., Giirakan B. Screening of blood glucose levels in healthy neonates // Singapore Med. J. 2010. Vol. 51, N 11. P. 853–835.

123. Kinnala A., Rikalainen H., Lapinleimu H., Parkkola R., Kormano М., Kero P. Cerebral magnetic resonance imaging and ultrasonography findings after neonatal hypoglycemia // Pediatrics. 1999. Vol. 103. P. 724–729.

124. Koivisto М., Blanco-Sequeiros М., Krause U. Neonatal sympomatic and asymptomatic hypoglycaemia: a follow-up study // Developmental medicine and child neurology. 1972. Vol. 14. P. 603–614.

125. Kompare М., Rizzo W. B. Mitochondrial fatty-acid oxidation disorders // Semin. Pediatr. Neurol. 2008. Vol. 15. P. 140–149.

126. Krinsley J. S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients // Mayo Clin. Proc. 2004. Vol. 79. P. 992–1000.

127. Ktorza A., Bihoreau М. Т., Nurjhan N., Picon L., Girard J. Insulin and glucagon during the perinatal period: secretion and metabolic effects on the liver // Biology of the neonate. 1985. Vol. 48. P. 204–220.

128. Kumari S., Bhargava S. K., Ahmed S. H., Ghosh S. Transient symptomatic hypoglycemia in the newborn // Indian Pediatr. 1971. Vol. 8. P. 762–769.

129. Levitsky L. L., Fisher D. E., Paton J. B. Fasting plasma levels of glucose, acetoacetate, D-hydroxybutyrate, glycerol and lactate in the baboon infant: correlation with cerebral uptake of substrates and oxygen // Pediatric research. 1977. Vol. 11. P. 298–302.

130. Lilien L. D., Pildes R. S., Srinivasan G., Voora S., Yeh T. F. Treatment of neonatal hypoglycemia with minibolus and intraveous glucose infusion // J. Pediatr. 1980. Vol. 97. P. 295–298.

131. Lilien L. D., Rosenfield R. L., Baccaro М. М., Pildes R. S. Hyperglycemia in stressed small premature neonates // J Pediatr. 1979. Vol. 94. P. 454–459.

132. Limesand S. W., Jensen J., Hutton J. C., Hay W. W. Jr. Diminished (3-Cell Replication Contributes to Reduced (3-Cell Mass in Fetal Sheep with Intrauterine Growth Restriction // Am. J. Physiol. Reg. Integr. Comp. Physiol. 2005. Vol. 288. P. 1297–1305.